Suppr超能文献

[D409H/D409H基因型戈谢病。酶替代疗法的疗效观察]

[Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].

作者信息

Castelló Girona F, Domínguez Luengo C, del Toro Riera M, Chabás Bergon A

机构信息

Servicio de Pediatría. Hospital Materno-Infantil Vall d'Hebron. Barcelona.

出版信息

An Esp Pediatr. 2001 Mar;54(3):310-2.

Abstract

Gaucher's disease is caused by mutations in the gene encoding glucocerebrosidase. The D409H mutation is the third most frequent mutation in Spain and has been associated with a particular phenotype, including oculomotor apraxia and cardiac valvular calcifications in late childhood. We report a 4-year-old patient, homozygous for the D409H mutation, who was diagnosed with Gaucher's disease at the age of 45days. Enzyme replacement therapy was started at the age of 2months. We report the patient's evolution after 4years of treatment.

摘要

戈谢病由编码葡糖脑苷脂酶的基因突变引起。D409H突变是西班牙第三常见的突变,与特定表型相关,包括儿童晚期的眼球运动失用和心脏瓣膜钙化。我们报告一名4岁患者,为D409H突变纯合子,45天时被诊断为戈谢病。2个月大时开始酶替代治疗。我们报告该患者治疗4年后的病情进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验